O'Connor Kevin J. reported acquisition or exercise transactions in this Form 4 filing.
Encompass Health Corp director Kevin J. O'Connor received a grant of 1,634 shares of Encompass Health Common Stock. The shares were awarded at no cash cost as part of his annual restricted stock unit grant under the Corporation's 2025 Omnibus Performance Incentive Plan. Following this equity award, O'Connor directly holds 11,563 shares of Encompass Health Common Stock, reflecting a routine compensation-related increase in his ownership stake.
Christie Edward M III reported acquisition or exercise transactions in this Form 4 filing.
Encompass Health Corp reported that director Edward M. Christie III received an annual equity award in the form of 1,634 shares of Encompass Health Common Stock on May 7, 2026. The shares were granted at $0.00 per share as restricted stock units under the company’s 2025 Omnibus Performance Incentive Plan, meaning they are compensation rather than a market purchase.
After this award, Christie directly owns 9,086 shares of Encompass Health Common Stock. This is a routine director compensation grant, not an open‑market buy or sale, and it does not reflect a discretionary trading decision.
Reidy Christopher R reported acquisition or exercise transactions in this Form 4 filing.
Encompass Health Corp director Christopher R. Reidy received an equity grant of 1,634 shares of Encompass Health Common Stock. The shares were awarded at a price of $0.00 per share as part of his annual grant of restricted stock units under the corporation's 2025 Omnibus Performance Incentive Plan.
Following this grant, Reidy directly holds 17,437 shares of Encompass Health Common Stock. This transaction reflects a compensation-related award rather than an open-market purchase or sale.
Hayes Cain A reported acquisition or exercise transactions in this Form 4 filing.
Encompass Health Corp director Cain A. Hayes reported receiving an annual grant of 1,634 shares of Encompass Health Common Stock, awarded as restricted stock units under the corporation's 2025 Omnibus Performance Incentive Plan. After this compensation-related award, Hayes directly holds 2,092 shares.
CARMICHAEL GREG D reported acquisition or exercise transactions in this Form 4 filing.
Encompass Health Corp director Greg D. Carmichael received an equity award of 1,634 shares of Encompass Health Common Stock. The shares were granted on 2026-05-07 as an annual grant of restricted stock units under the Corporation's 2025 Omnibus Performance Incentive Plan. Following this grant, Carmichael directly holds 20,320 shares of Encompass Health Common Stock.
Williams Terrance reported acquisition or exercise transactions in this Form 4 filing.
Encompass Health Corp director Terrance Williams received an equity grant of 1,634 shares of Encompass Health Common Stock. The shares were awarded at no cash cost as an annual grant of restricted stock units under the company’s 2025 Omnibus Performance Incentive Plan, bringing his direct holdings to 16,830 shares.
KATZ LESLYE G reported acquisition or exercise transactions in this Form 4 filing.
Encompass Health Corp director Leslye G. Katz received an annual grant of 1,634 shares of Encompass Health Common Stock on May 7, 2026. The award was granted at no cash cost as restricted stock units under the company’s 2025 Omnibus Performance Incentive Plan.
Following this grant, Katz directly holds 49,558 shares of Encompass Health Common Stock. This is a routine equity compensation award rather than an open-market purchase or sale, so it does not reflect a discretionary trading decision in the company’s stock.
HERMAN JOAN E reported acquisition or exercise transactions in this Form 4 filing.
Encompass Health Corp director Joan E. Herman received a grant of 1,634 Encompass Health common shares as a compensation award. The shares were granted at no cash cost to Herman as part of an annual restricted stock unit award under the corporation's 2025 Omnibus Performance Incentive Plan. Following this grant, Herman directly holds 49,558 shares of Encompass Health common stock. This is a routine equity compensation grant rather than an open-market purchase or sale.
SCHLICHTING NANCY M reported acquisition or exercise transactions in this Form 4 filing.
Encompass Health Corp director Nancy M. Schlichting received an annual grant of 1,634 restricted stock units of Encompass Health Common Stock at no cost under the corporation's 2025 Omnibus Performance Incentive Plan. Following this grant, she directly holds 22,932 shares of Encompass Health Common Stock.
Encompass Health Corporation reported strong first-quarter 2026 growth, with net operating revenues of $1,586.6 million, up 9.0% from $1,455.4 million a year earlier, driven by higher patient volumes and improved pricing.
Net income attributable to Encompass Health rose to $194.5 million from $151.5 million, and diluted EPS increased to $1.93 from $1.48. Adjusted EBITDA reached $348.8 million versus $313.6 million. Cash from operating activities was $313.1 million, supporting continued hospital expansion, dividends, and share repurchases while managing long-term debt maturities beginning in 2028.